NCT04211441View on ClinicalTrials.gov

Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System for Treatment of Atrial and Ventricular Arrhythmias

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

September 2, 2019

Study Completion Date

September 18, 2020

Conditions
Atrial FibrillationAtrial FlutterVentricular Tachycardia
Interventions
DEVICE

Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System

Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System

Trial Locations (2)

Unknown

Homolka Hospital, Prague

Institute Klinicke a Experimentalni Mediciny, Prague

All Listed Sponsors
lead

Medtronic Cardiac Ablation Solutions

INDUSTRY

NCT04211441 - Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System for Treatment of Atrial and Ventricular Arrhythmias | Biotech Hunter | Biotech Hunter